TELEPHONE: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
The report provides comprehensive information on the therapeutics under development for Gaucher Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Gaucher Disease and features dormant and discontinued projects. report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Read More At: http://www.researchbeam.com/gaucher-disease-pipeline-review-h12016-market
Scope - The report provides a snapshot of the global therapeutic landscape of Gaucher Disease - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report summarizes all the dormant and discontinued pipeline projects - The report reviews latest news related to pipeline therapeutics for Gaucher Disease
Reasons to buy - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify potential new clients or partners in the target demographic - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
List of Figures Number of Products under Development for Gaucher Disease, H1 2016 10 Number of Products under Development for Gaucher Disease Comparative Analysis, H1 2016 11 Number of Products under Development by Companies, H1 2016 12 Number of Products under Investigation by Universities/Institutes, H1 2016 13 Comparative Analysis by Clinical Stage Development, H1 2016 14 Comparative Analysis by Early Stage Products, H1 2016 15 Assessment by Monotherapy Products, H1 2016 31 Number of Products by Targets, H1 2016 32 Number of Products by Stage and Targets, H1 2016 32 Number of Products by Mechanism of Actions, H1 2016 34 Number of Products by Stage and Mechanism of Actions, H1 2016 34 Number of Products by Routes of Administration, H1 2016 36 Number of Products by Stage and Routes of Administration, H1 2016 36 Number of Products by Molecule Types, H1 2016 38 Number of Products by Stage and Molecule Types, H1 2016 38 Enquire More At: http://www.researchbeam.com/gaucher-disease-pipeline-review-h12016-market/enquire-about-report
Visit us at http://www.researchbeam.com/gaucher-disease-pipeline-reviewh1-2016-market
Stay With Us:
TELEPHONE: +1 (800) 910-6452 DIRECT: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States